Akero Therapeutics Inc (NASDAQ:AKRO)
| 38.10 Delayed Data As of 3:59pm ET |  -2.13 / -5.29%Today’s Change | 7.52 Today|||52-Week Range 54.88 | -30.47% Year-to-Date |
Institutional investors hold a majority ownership of AKRO through the 94.19% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended March 2019, these large investors purchased a net $4.8 million shares.
| Other institutional | 62.51% |
| Mutual fund holders | 31.69% |
| Individual stakeholders | 30.99% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/31/2022 | SSGA FUNDS MANAGEMENT, INC. Bought 2.0 Million shares of Akero Therapeutics Inc |
| 12/31/2022 | REDMILE GROUP LLC Bought 1.0 Million shares of Akero Therapeutics Inc |
| 12/31/2022 | T. ROWE PRICE ASSOCIATES, INC. (... Bought 938.6 Thousand shares of Akero Therapeutics Inc |
Top 10 Owners of Akero Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Avidity Partners Management LP | 8.18% | 3,825,000 | 174,075,750 | +703,000 | +22.52% |
| Janus Henderson Investors US LLC | 7.13% | 3,334,661 | 151,760,422 | -937,724 | -21.95% |
| Alkeon Capital Management LLC | 6.94% | 3,243,915 | 147,630,572 | +81,656 | +2.58% |
| Redmile Group LLC | 5.63% | 2,632,912 | 119,823,825 | +1,041,827 | +65.48% |
| SSgA Funds Management, Inc. | 5.35% | 2,500,969 | 113,819,099 | +1,953,347 | +356.70% |
| BlackRock Fund Advisors | 5.16% | 2,414,484 | 109,883,167 | +604,025 | +33.36% |
| T. Rowe Price Associates, Inc. (I... | 5.13% | 2,401,037 | 109,271,194 | +938,613 | +64.18% |
| Baker Bros. Advisors LP | 5.07% | 2,368,378 | 107,784,883 | 0 | 0.00% |
| The Vanguard Group, Inc. | 4.42% | 2,064,859 | 93,971,733 | +368,837 | +21.75% |
| Marshall Wace LLP | 3.22% | 1,503,364 | 68,418,096 | +752,524 | +100.22% |
Top 10 Mutual Funds Holding Akero Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| SPDR S&P Biotech ETF | 3.38% | 1,579,666 | 71,890,600 | -14,070 | -0.88% |
| ACAP Strategic Fund | 3.31% | 1,549,936 | 70,537,587 | +42,180 | +2.80% |
| Vanguard Total Stock Market Index... | 2.92% | 1,363,342 | 62,045,694 | +1,683 | +0.12% |
| T Rowe Price New Horizons Fund | 2.46% | 1,150,107 | 52,341,370 | +771,217 | +203.55% |
| Janus Henderson Global Life Scien... | 2.16% | 1,011,052 | 46,012,977 | -94,005 | -8.51% |
| Janus Henderson Capital Funds Plc... | 1.75% | 817,266 | 37,193,776 | -11,971 | -1.44% |
| iShares Russell 2000 ETF | 1.63% | 763,272 | 34,736,509 | -2,412 | -0.32% |
| Advantage Advisers Xanthus Fund | 0.93% | 435,044 | 19,798,852 | +9,604 | +2.26% |
| Stichting Pensioenfonds ABP (Glob... | 0.92% | 430,146 | 19,575,944 | +15,310 | +3.69% |
| Vanguard Extended Market Index Fu... | 0.88% | 409,814 | 18,650,635 | +858 | +0.21% |